Here's What Key Metrics Tell Us About Globe Life (GL) Q1 Earnings

Zacks
05-01

For the quarter ended March 2025, Globe Life (GL) reported revenue of $1.48 billion, up 5.4% over the same period last year. EPS came in at $3.07, compared to $2.78 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $1.49 billion, representing a surprise of -0.52%. The company delivered an EPS surprise of -5.25%, with the consensus EPS estimate being $3.24.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Globe Life performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Revenue- Total premium: $1.20 billion versus $1.20 billion estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +4.8% change.
  • Revenue- Net investment income: $280.61 million versus $282.13 million estimated by six analysts on average. Compared to the year-ago quarter, this number represents a -0.7% change.
  • Revenue- Life premium: $829.86 million versus $834.65 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +3.2% change.
  • Revenue- Health premium: $369.79 million versus the four-analyst average estimate of $366.04 million. The reported number represents a year-over-year change of +8.4%.
  • Revenue- Life premium- Other agencies: $50.22 million versus $49.71 million estimated by three analysts on average.
  • Revenue- Health Premium- United American: $159.85 million versus $153.84 million estimated by three analysts on average.
  • Revenue- Health premium- Liberty National: $47.92 million versus the three-analyst average estimate of $48.43 million.
  • Life Underwriting Margin - Other: $45.12 million versus $32.35 million estimated by three analysts on average.
  • Revenue - Health premium- Direct to Consumer: $18.98 million versus the three-analyst average estimate of $18.66 million.
  • Revenue- Life premium- Direct to Consumer: $245.60 million versus the three-analyst average estimate of $245.66 million.
  • Revenue- Life premium- American Income Exclusive: $437.87 million compared to the $442.14 million average estimate based on three analysts.
  • Revenue- Life premium- Liberty National Exclusive: $96.18 million versus $96.06 million estimated by three analysts on average.
View all Key Company Metrics for Globe Life here>>>

Shares of Globe Life have returned -6.2% over the past month versus the Zacks S&P 500 composite's -0.2% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Globe Life Inc. (GL) : Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10